Waksal’s gene therapy spinoff MeiraGTx says it’s time to fly with an $86M IPO – Endpoints News
Endpoints News |
Waksal's gene therapy spinoff MeiraGTx says it's time to fly with an $86M IPO
Endpoints News Three years after Sam Waksal's Kadmon spun out its gene therapy tech into a startup called MeiraGTx, the New York-based biotech says it's ready to come out to play on Nasdaq. Waksal, an ex-con once sentenced to prison for his insider trading conviction … |
